Finance

Cellular-engineering-focused company announces completion of private placement

Published in Cancer Weekly, February 8th, 2005

Chromos Molecular Systems, Inc., (CHR) announced that it has completed the private placement of 2,215,085 units at $0.48 per share for total gross proceeds of $1,063,241.

Each unit consists of 1 common share and one-half of 1 common share purchase warrant. Each whole warrant will entitle the holder to purchase 1 additional common share of the company at a price of $0.60 for a period of 24 months from the closing date of the private placement.

The proceeds will be used to fund the on-going development of the company's cellular-engineering and cell-therapy programs and for general working capital purposes.

The company expects this...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry